Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

RNAseq analysis of normal childhood brain tissue

ABSTRACT: Normal brain RNAseq data provides a critical comparitor for evaluation of gene expression changes in childhood brain tumors.

ORGANISM(S): Homo sapiens

PROVIDER: GSE244124 | GEO | 2024/02/05

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

RNAseq analysis of normal childhood brain tissue

Project description:RNAseq analysis of normal childhood brain tissue

| PRJNA1021260 | ENA

Pediatric Neoplastic and Normal Brain RNAseq Data

Project description:RNAseq analysis across the spectrum of childhood brain tumors and normal brain tissue.

2024-03-06 | GSE243682 | GEO

RNAseq analysis of childhood posterior fossa subgroup A ependymoma

Project description:Posterior fossa subgroup A (PFA) ependymoma is a brain tumor of childhood with a high rate of recurrence. Here we have performed RNAseq on a longitudinal cohort of patient samples obtained at presentation and at recurrence(s), in order to identify the biological correlates of treatment failure and tumor evolution.

2023-06-01 | GSE226957 | GEO

Single-cell RNAseq of childhood medulloblastoma

Project description:Single-cell RNAseq of childhood medulloblastoma

| PRJNA649773 | ENA

Pediatric Neoplastic and Normal Brain RNAseq Data

Project description:Pediatric Neoplastic and Normal Brain RNAseq Data

| PRJNA1019377 | ENA

Childhood brain tumors instructs cranial haematopoiesis and immunotolerance

Project description:Childhood brain tumors instructs cranial haematopoiesis and immunotolerance

| PRJNA1188615 | ENA

Childhood brain tumours instruct cranial haematopoiesis and immunotolerance [scRNAseqTCR postTx]

Project description:Recent research has revealed a remarkable role for immunosurveillance in healthy and diseased brains, dispelling the notion that this organ is a passive immune-privileged site. Better understanding of how this immunosurveillance operates could improve the treatment of neurological diseases. Here, using a novel genetically engineered mouse model of ZFTA-RELA ependymoma–a childhood brain tumour–we characterised an immune circuit between the tumour and antigen presenting, haematopoietic stem/progenitor cells (HSPCs) in the skull bone marrow. The presentation of antigens in the cerebrospinal fluid (CSF) by HSPCs to CD4+ T cells, biased HSPCs lineages toward myelopoiesis and polarised CD4+ T-cells to regulatory T cells (T-regs), culminating in tumour immunotolerance. Remarkably, a single infusion of antibodies directed against cytokines enriched in the CSF of mice bearing ZFTA-RELA ependymomas, choroid plexus carcinomas or Group-3 medulloblastoma–all aggressive childhood brain tumours–disrupted this process and caused profound tumour regression. These data unmask a mechanism by which skull bone marrow-derived HSPCs and CD4+ T cells cooperate to promote the immunotolerance of childhood brain tumours. Antibodies that disrupt this immunosurveillance could prove an effective therapy for these cancers that are less toxic than current treatments.

2025-12-01 | GSE300890 | GEO

RNAseq analysis of childhood posterior fossa subgroup A ependymoma

Project description:RNAseq analysis of childhood posterior fossa subgroup A ependymoma

| PRJNA942443 | ENA

Childhood brain tumors instruct cranial haematopoiesis and immunotolerance [endpoint Fus1 GEX]

Project description:Recent research has revealed a remarkable role for immunosurveillance in healthy and diseased brains, dispelling the notion that this organ is a passive immune-privileged site1–3. Better understanding of how this immunosurveillance operates could improve the treatment of neurological diseases. Here, using a novel genetically engineered mouse model of ZFTA-RELA ependymoma4–a childhood brain tumour–we characterised an immune circuit between the tumour and antigen presenting, haematopoietic stem/progenitor cells (HSPCs) in the skull bone marrow. The presentation of antigens in the cerebrospinal fluid (CSF) by HSPCs to CD4+ T cells, biased HSPCs lineages toward myelopoiesis and polarised CD4+ T-cells to regulatory T cells (T-regs), culminating in tumour immunotolerance. Remarkably, a single infusion of antibodies directed against cytokines enriched in the CSF of mice bearing ZFTA-RELA ependymomas, choroid plexus carcinomas or Group-3 medulloblastoma–all aggressive childhood brain tumours–disrupted this process and caused profound tumour regression. These data unmask a mechanism by which skull bone marrow-derived HSPCs and CD4+ T cells cooperate to promote the immunotolerance of childhood brain tumours. Antibodies that disrupt this immunosurveillance could prove an effective therapy for these cancers that are less toxic than current treatments.

2025-12-01 | GSE300889 | GEO

RNAseq of human brain cell lines

Project description:RNAseq of human brain cell lines

| PRJNA672108 | ENA